Fundz

Absco Therapeutics reported raising $5 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEAug 27, 2025

Amount Raised

$5 Million

$5 Million sold, per SEC Form D (first sale Aug 18, 2025)

Round Type

Venture

AllstonBiotechnology

Quick answer

Absco Therapeutics raised $5 Million in a funding round, dated August 18, 2025. Absco Therapeutics is based in Allston, Massachusetts, United States.

How much did Absco Therapeutics raise?
Absco Therapeutics raised $5 Million in a funding round on August 18, 2025.
What does Absco Therapeutics do?
Absco Therapeutics, Inc. (AbscoTx) is a stealth phase immune engineering company born out of collaborative work between clinicians at MGH and BWH, engineers at MIT, and an experienced team of biotech entrepreneurs and..
Where is Absco Therapeutics based and how big is it?
Absco Therapeutics is based in Allston, Massachusetts, United States. Fundz records about 7 employees.
Who are the decision-makers at Absco Therapeutics?
Fundz holds 1 contact at Absco Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Absco Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Cartography Biosciences raised $67M (Series B) on October 2, 2025.
  • Motor City Dental Partners raised an undisclosed amount (Debt Financing) on October 2, 2025.
  • Leyden Labs raised $35M (Funding Round) on October 2, 2025.
  • OncoC4 raised $50M (Series B) on October 2, 2025.
  • Kihealth raised $5M (Seed) on October 2, 2025.
  • Rockcliffe Labs raised $59M (Post-IPO Equity) on October 2, 2025.

Who to call at Absco Therapeutics, and when

A new round usually means Absco Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Absco Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Absco Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Absco Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Absco Therapeutics

Location

127 WESTERN AVENUE

Allston, Massachusetts, United States

About

Absco Therapeutics, Inc. (AbscoTx) is a stealth phase immune engineering company born out of collaborative work between clinicians at MGH and BWH, engineers at MIT, and an experienced team of biotech entrepreneurs and translational medicine experts.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Absco Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Absco Therapeutics's next move

See what Strategic adds

Absco Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.